Molecular blood grouping of donors

Transfusion and Apheresis Science

Volumn 50, Issue 2, 2014, Pages 175-182

  St Louis, Maryse ^a  

^a Recherche et développement Héma Québec   (Canada)

Author keywords

Alloimmunization; Antigen negative inventory; Assay development; Donors; Drymatching; Genotyping; Platforms

Indexed keywords

BLOOD GROUP ANTIGEN; CELL ANTIGEN; ERYTHROCYTE ANTIGEN; NEUTROPHIL ANTIGEN; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG;

BLOOD DONOR; BLOOD GROUP SYSTEM; BLOOD GROUP TYPING; BLOOD TRANSFUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HEMAGGLUTINATION; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR CLONING; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NEUTROPHIL; PHENOTYPE; PREDICTION; PYROSEQUENCING; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; THROMBOCYTE; TRANSFUSION MEDICINE; DONOR SELECTION; FEMALE; GENOTYPE; MALE; PROCEDURES;

BLOOD DONORS; BLOOD GROUPING AND CROSSMATCHING; DONOR SELECTION; FEMALE; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; MALE;

EID: 84900484386     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2014.02.012     Document Type: Review

References (80)

1. Hervé P, Muller J-Y, Tiberghien P. La transfusion sanguine demain, 1st ed., Paris, John Libbey Eurotext; 2005, p. 279.
2. ISBT. http://www.isbtweb.org.
3. Ballif B.A., Helias V., Peyrard T., Menanteau C., Saison C., Lucien N., et al. Disruption of SMIM1 causes the Vel- blood type. EMBO Mol Med 2013, 5:751-761.
4. Storry J.R., Jöud M., Kronborg Christophersen M., Thuresson B., Akerström B., Nilsson Sojka B., et al. Homozygosity for a null allele of SMIM1 defines the Vel-negative blood group phenotype. Nat Genet 2013, 45:537-541.
5. Cvejic A., Haer-Wigman L., Stephens J.C., Kostadima M., Smethurst P.A., Frontini M., et al. SMIM1 underlies the Vel blood group and influences red blood cell traits. Nat Genet 2013, 45:542-545.
6. Garratty G. Advances in red blood cell immunology 1960 to 2009. Transfusion 2010, 50:526-535.
7. Lomas-Francis C. Testing for rare blood donors by DNA analysis. ISBT Sci Series 2006, 1:213-219.
8. Daniels G. The molecular genetics of blood group polymorphism. Transpl Immunol 2005, 14:143-153.
9. Anstee D.J. Red cell genotyping and the future of pretransfusion testing. Blood 2009, 114:248-256.
10. Hillyer C.D., Shaz B.H., Winkler A.M., Reid M. Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services. Transfus Med Rev 2008, 22:117-132.
11. Veldhuisen B., de Haas C.E., Van der Schoot M. Blood group genotyping: from patient to high-throughput donor screening. Vox Sang 2009, 97:198-206.
12. Tournamille C. Molecular biology methods in immunohematology. Transfus Clin Biol 2013, 20:72-79.
13. Denomme G.A., Van Oene M. High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes. Transfusion 2005, 45:660-666.
14. St-Louis M., Perreault J., Lemieux R. Extended blood grouping of blood donors with automatable PCR-ELISA genotyping. Transfusion 2003, 43:1126-1132.
15. Denomme G.A., Johnson S.T., Pietz B.C. Mass-scale red cell genotyping of blood donors. Transfus Apher Sci 2011, 44:93-99.
16. Storry J.R. New technologies to replace current blood typing reagents. Curr Opin Hematol 2007, 14:677-681.
17. Gassner C., Meyer S., Frey B.M., Vollmert C. Matrix-assisted laser desorption/ionisation, time-of-flight mass spectrometry-based blood group genotyping - the alternative approach. Transfus Med Rev 2013, 27:2-9.
18. Avent N.D. Large-scale blood group genotyping - clinical implications. Br J Haematol 2009, 144:3-13.
19. Avent N.D., Martinez A., Flegel W.A., Olsson M.L., Scott M.L., Nogués N., et al. The Bloodgen Project of the European Union 2003-2009. Transfus Med Hemother 2009, 36:162-167.
20. Reid M.E. Transfusion in the age of molecular diagnostics. Hematology Am Soc Hematol Educ Program 2009, 171-177.
21. Gabriel C., Stabentheiner S., Danzer M., Pröll J. What next? The next transit from biology to diagnostics: next generation sequencing for immunogenetics. Transfus Med Hemother 2011, 38:308-317.
22. Denomme G.A. Prospects for the provision of genotyped blood for transfusion. Br J Haematol 2013, 163:3-9.
23. Beiboer S.H.W., Wieringa-Jelsma T., Maaskant-Van Wijk P.A., van der Schoot C.E., van Zwieten R., Roos D., et al. Rapid genotyping of blood group antigens by multiplex polymerase chain reaction and DNA microarray hybridization. Transfusion 2005, 45:667-679.
24. Wagner F.F., Bittner R., Petershofen E.K., Doescher A., Müller T.H. Cost-efficient sequence-specific priming-polymerase chain reaction screening for blood donors with rare phenotypes. Transfusion 2008, 48:1169-1173.
25. Wagner F.F. Screening donors for rare antigen constellations. Transfus Med Hemother 2009, 36:199-203.
26. Patel S., Billingsley K.L., Modha N., Ray B., Moulds J.M. Red cell blood group typing on the Luminex platform. Transfusion 2010, 50(suppl.):39A.
27. Monteiro F., Tavares G., Ferreira M., Amorim A., Bastos P., Rocha C., et al. Cunha Ribeiro L, Technologies involved in molecular blood group genotyping. Vox Sang 2011, 101(suppl. 1):1.
28. Nieves S., Brunker P.A., Flegel W.A. A novel approach to multiplex genotyping for the Scianna, Colton and Dombrock blood groups using ligation detection reaction. Transfusion 2011, 51(suppl.):165A-166A.
29. Polin H., Danzer M., Pröll J., Hofer K., Heilinger U., Zopf A., et al. Introduction of a real-time based blood group genotyping approach. Vox Sang 2008, 95:125-130.
30. Montpetit A., Phillips M.S., Mongrain I., Lemieux R., St-Louis M. High-throughput molecular profiling of blood donors for minor red blood cell and platelet antigens. Transfusion 2006, 46:841-848.
31. Perreault J., Lavoie J., Painchaud P., Côté M., Constanzo-Yanez J., Côté R., et al. Set-up and routine use of a database of 10555 genotyped blood donors to facilitate the screening of compatible blood components for alloimmunized patients. Vox Sang 2009, 97:61-68.
32. St-Louis M., Perreault J., Lavoie J., Émond J., St-Laurent J., Long A., et al. Genotyping of 21,000 blood donors in Quebec and RHD analysis. Transfus Clin Biol 2010, 17:242-248.
33. Jungbauer C., Hobel C.M., Schwartz D.W.M., Mayr W.R. High-throughput multiplex PCR genotyping for 35 red blood cell antigens in blood donors. Vox Sang 2012, 102:234-242.
34. Latini FR, Gazito D, Arnoni CP, Muniz JG, de Madeiros Person R, Carvalho FO, Baleotti W, Castilho L, Barreto JA. A new strategy to identify rare blood donors: single polymerase chain reaction multiplex SNaPshot reaction for detection of 16 blood group allele. Blood Transfus 2013 [doi: 10.2450/2013.0242-12:1-8].
35. Hopp K., Weber K., Bellissimo D., Johnson S.T., Pietz B. High-throughput red blood cell antigen genotyping using a nanofluidic real-time polymerase chain reaction platform. Transfusion 2010, 50:40-46.
36. Weber K.M., Fueger J.T., Piefer C.L., Leszczynski L.A., Kalvelage M.L., Sauer D.E., et al. Identifying rare blood donors: a study in on-time high-throughput red cell genotyping. Transfusion 2010, 50(suppl.):174A-175A.
37. Haer-Wigman L., Ji Y., Lodén M., de Haas M., van der Schoot C.E., Veldhuisen B. Comprehensive genotyping for 18 blood group systems using a multiplex ligation-dependent probe amplification assay shows a high degree of accuracy. Transfusion 2013, 53(suppl.):2899-2909.
38. Veldhuisen B., Wigman L., Rapun N., Cheroutre G., Loden M., de Haas M., et al. Performance of two new methods for high-throughput genotyping of blood group antigens: IDCore+ and MLPA. Vox Sang 2011, 101(suppl. 1):64.
39. Haer-Wigman L., Veldhuisen B., Jonkers R., Lodén M., Madgett T.E., Avent N.D., et al. RHD and RHCE variant and zygosity genotyping via multiplex ligation-dependent probe amplification. Transfusion 2013, 53:1559-1574.
40. Avent D., Martinez A., Flegel W., Olsson M., Nogues N., Pisaka M., et al. The Bloodgen project: toward mass scale genotyping for human blood group antigens. Vox Sang 2006, 91(suppl. 3):5PS-38-01.
41. Progenika's. http://:www.progenika.com.
42. Molano-Bilbao A., Garcia-Crespo D., Ciriza I., Martinez A., Tejedor D., Ochoa G., et al. Relevance of blood group genotyping product flexibility. Transfusion 2011, 51(suppl.):170A.
43. Garcia-Crespo D., Apraiz I., Viegas M., Ciriza I., Molano-Bilbao A., Martinez A., et al. Evaluation of IDCore+, a high-throughput red blood cells genotyping test. Vox Sang 2011, 101(suppl. 1):265.
44. Azkarate Ania M.N., Rubia Tejero M., Piedrabuena Royo M., Renovales Garcia A., Lopez M., Alonso Sanchez M., et al. Clinical validation of a red blood group genotyping bead array. Vox Sang 2011, 101(suppl.1):264.
45. Frassati C. HPA genotyping with IDHPA (Progenika). Vox Sang 2011, 101(suppl. 1):267.
46. Haimila K., Rapun Mas N., Tenkanen H. Red blood cell and platelet antigen genotyping with BLOODchip ID kits by Progenika/Grifols based on Luminex technology. Vox Sang 2011, 101(suppl. 1):267-268.
47. Pisacka M., Sklenarova M., Kralova M. BLOODchip genotyping results of 200 samples from the Czech population. Vox Sang 2011, 101(suppl. 1):268.
48. Reid M.E., Vissavajjhala P., Hashmi G.P., Shariff T., Seul M., Hue-Roye K., et al. Blood group antigen typing by DNA analysis in a custom bead array format. Transfusion 2004, 44 (suppl.):22A.
49. Hashmi G., Shariff T., Zhang Y., Cristobal J., Chau C., Seul M., et al. Determination of 24 minor red blood cell antigens for more than 2000 blood donors by high-throughput DNA analysis. Transfusion 2007, 47:736-747.
50. Immucor's. http://www.immucor.com.
51. Alexandre A., Bubeaux I., Kappler-Gratias S., Pham B.N., Smallridge G. Multi-parametric study for validation of Bioarray HEA BeadChip DNA based method for determining blood group phenotypes. Vox Sang 2011, 101(suppl. 1):262.
52. Castilho M., Costa C., Guelsin G., Pellegrino J. A DNA-based matching approach that prevents the alloimmunization and facilitates the transfusion support for sickle cell disease patients. Vox Sang 2011, 101(suppl. 1):64-65.
53. Smallbridge J., Villa M.A., Revelli N., Marconi M., Pham B.N., Kappler-Gratias S., et al. A multi-centre study comparing the performance of the Bioarray HEA BeadChip assay with established methods for determination of red blood cell antigens. Vox Sang 2011, 101(suppl. 1):270-271.
54. Hult A., Hellberg A., Wester E.S., Olausson P., Storry J.R., Olsson M.L. Blood group genotype analysis for the quality improvement of reagent test red blood cells. Vox Sang 2005, 88:265-270.
55. Kappler-Gratias S., Peyrard T., Beolet M., Amiranoff D., Menanteau C., Dubeaux I., et al. Blood group genotyping by high-throughput DNA analysis applied to 356 reagent red blood cell samples. Transfusion 2011, 51:36-42.
56. Le Goff G.C., Brès J.-C., Rigal D., Blum L.J., Marquette C.A. Robust, high-throughput solution for blood group genotyping. Anal Chem 2010, 82:6185-6192.
57. Bres J.-C., Le Goff G.C., Marquette C.A., Blum L., Guitton C., Verdier M., et al. High throughput filtering assays as a future multiplex blood group genotyping in blood banks. Vox Sang 2010, 99(suppl. 1):364.
58. AXO Science's. http://www.axoscience.com.
59. Delaney M. Proficiency testing for blood group genotyping. Transfusion 2013, 53(suppl.):2847-2849.
60. Kroll H., Carl B., Santoso S., Bux J., Bein G. Workshop report on the genotyping of blood cell alloantigens. Transfus Med 2001, 11:211-219.
61. Daniels G., Van der Schoot C.E., Olsson M.L. Report of the first international workshop on molecular blood group genotyping. Vox Sang 2005, 88:136-142.
62. Daniels G., Van der Schoot C.E., Olsson M.L. Report of the second international workshop on molecular blood group genotyping. Vox Sang 2007, 93:83-88.
63. Daniels G., Van der Schoot C.E., Gassner C., Olsson M.L. Report of the third international workshop on molecular blood group genotyping. Vox Sang 2009, 96:337-343.
64. Daniels G., Van der Schoot C.E., Olsson M.L. Report of the forth international workshop on molecular blood group genotyping. Vox Sang 2011, 101:327-332.
65. Flegel W., Chiosea I., Sachs U., Bein G. External quality assessment in molecular immunohematology: the INSTAND proficiency test program. Transfusion 2013, 53:2850-2858.
66. Boyle J., Thorpe S.J., Hawkins J.R., Lockie C., Fox B., Matejtschuk P., et al. International reference reagents to standardise blood group genotyping: evaluation of candidate preparations in an international collaborative study. Vox Sang 2013, 104:144-152.
67. Seltsam A., Doescher A. Sequence-based typing of human blood groups. Transfus Med Hemother 2009, 36:204-212.
68. Edinur H.A., Dunn P.P.J., Lea R.A., Chambers G.K. Molecular approaches to transfusion medicine in Polynesians and Maori in New Zealand. Int J Immunogenet 2013, 40:460-470.
69. Dragan A.I., Goldberg K., Elbaz A., Marks R., Zhang Y., Geddes C.D. Two-color, 30 second microwave-accelerated metal-enhanced fluorescence DNA assays: a new rapid catch and signal (RCS) technology. J Immunol Methods 2011, 366:1-7.
70. Brouard D., Ratelle O., Bracamonte A.G., St-Louis M., Boudreau D. Direct molecular detection of SRY gene from unamplified genomic DNA by metal-enhanced fluorescence and FRET. Anal Methods 2013, 5:6896-6899.
71. Mountford J.C., Turner M. In vitro production or red blood cells. Transfus Apher Sci 2011, 45:85-89.
72. Peyrard T., Bardiaux L., Krause C., Kobari L., Lapillonne H., Andreu G., et al. Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: potential applications for alloimmunized patients and rare blood challenges. Transfus Med Rev 2011, 25:206-216.
73. Travali S., Distefano R., Fidone C., Licitra V., Spadola V., Bonomo L., et al. Do extended-matched red blood cells (RBC) improve transfusion yield?. Vox Sang 2011, 101(suppl. 1):266.
74. Chou S.T., Jackson T., Vege S., Smith-Whitley K., Friedman D.F., Westhoff C.M. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 2013, 122:1062-1071.
75. Metzker M.L. Sequencing technologies - the next generation. Nat Rev Genet 2010, 11:31-46.
76. Robinson P.N., Krawitz P., Mundlos S. Strategies for exome and genome sequence data analysis in disease-gene discovery projects. Clin Genet 2011, 80:127-132.
77. Ostergaard P., Simpson M.A., Jeffery S. Massively parallel sequencing and identification of genes for primary lymphoedema: a perfect fit. Clin Genet 2011, 80:110-116.
78. Red blood cell terminology. http://www.isbtweb.org/working-parties/red-cell-immunogenetics-and-blood-group-terminology/blood-group-terminology.
79. EMBL-EBI. http://www.ebi.ac.uk/ipd/hpa/Table2.html.
80. Fung Y.L., Minchinton R.M., Fraser J.F. Neutrophil antibody diagnostics and screening: review of the classical versus the emerging. Vox Sang 2011, 101:282-290.